Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

A clinical study of MK-6916 in healthy people (MK-6916-006) Ended

2025-521487-36-00 Acute and chronic Pain 2025-06-02
Defining the Glucagon Unit: Investigating the Impact on Energy Expenditure and Glucose Level Deviation in healthy volunteers Ended

2024-510885-17-01 Obesity 2025-06-01
A Study to Understand What the Body Does to the Study Medicine Called PF-07976016 When Taken by Healthy Adults Ended

2024-518535-11-00 Obesity 2025-05-30
Investigate Drug-Drug Interactions between LVDS (Levonorgestrel Vaginal Delivery System) and Tampons and Lubricants in Healthy Female Partic… Ended

2025-520517-32-00 No medical condition. 2025-05-29
A study to learn about the study medicine called PF-08046032 in people with advanced cancers. Ended

2024-517756-35-00 Advanced lymphomas (classic Hodgkin lymphoma [cHL], per 2025-05-28
A trial to learn about how multiple doses of itraconazole change how AZD5004 moves throughout the body over time in healthy adults and how m… Ended

2024-518467-35-00 Not applicable, healthy volunteers 2025-05-28
Investigation of Drug-Drug Interactions between LVDS (Levonorgestrel Vaginal Delivery System) and Miconazole in Healthy Female Participants. Ended

2025-520516-33-00 No medical condition. 2025-05-28
Bioavailability study of stiripentol after single oral administration of two different formulations (capsule and oral suspension) in 24 heal… Ended

2024-520103-38-00 Dravet syndrome 2025-05-26
A study to test how well multiple doses of BI 3810477 are tolerated by healthy adults. Ended

2024-519327-20-00 Healthy volunteer trial 2025-05-21
A study in healthy people to test how empagliflozin is taken up in the body when taken as a whole tablet or dissolved in water and mixed wit… Ended

2025-520813-29-00 Healthy volunteer trial 2025-05-21
A study in healthy people to test how 3 different formulations of BI 764198 are taken up in the body and how this is influenced by food Ended

2024-519615-34-00 healthy volunteer trial 2025-05-19
A multicentric, open-label, non-randomized study to evaluate the pharmacokinetic, safety and tolerability of ITF2357 given as an oral single… Ended

2024-513577-43-00 Participants with normal hepatic function 2025-05-16
A Study on Oral and Intranasal Forms in Healthy Volunteers using Pharmacokinetic Modeling Ended

2024-515461-34-00 healthy volunteers 2025-05-14
A randomised, open-label, 5-period, cross-over trial to assess the pharmacokinetics and safety of 3 oral solid formulations of buloxibutid (… Ended

2025-520702-35-00 Idiopahtic pulmonary fibrosis 2025-05-14
A randomised, assessor-blinded, controlled, healthy volunteer, Phase I study to assess skin irritation and sensitization potential of a nove… Ended

2024-518038-10-00 None. Healthy subjects 2025-05-12
Phase 1 clinical trial to evaluate the safety, tolerability and pharmacokinetics of multiple daily doses of IM-250 in healthy volunteers. Ended

2024-519482-22-00 Healthy Volunteers 2025-04-30
A study in healthy people to test whether erythromycin influences the amount of BI 1291583 in the blood. Ended

2024-515795-12-00 Healthy volunteer trial 2025-04-29
Drug-Drug Interaction Study With BIA 28-6156 and Clarithromycin, Midazolam, and Dabigatran Etexilate in Healthy Participants Ended

2025-520840-14-00 Healthy volunteers 2025-04-29
A clinical study of MK-1403 in healthy people (MK-1403-002) Ended

2023-507239-39-00 Atherosclerosis 2025-04-25
An Accessorised Prefilled Syringe to an Autoinjector Pharmacokinetic Bridging Study of Tozorakimab Ended

2024-511840-22-00 Inflammation 2025-04-22
A study to investigate the bioavailability of the SAR444656 test formulation and the food effect on the SAR444656 test formulation in health… Ended

2024-515621-28-00 Healthy Volunteer 2025-04-17
A phase 1, open-label trial in healthy subjects and in subjects with diabetes investigating pharmacokinetics, tolerability, safety, and food… Ended

2024-515078-28-00 Diabetic Retinopathy 2025-04-16
Accelerator-based BNCT for head and neck carcinoma Ended

2024-515036-71-00 Head and neck carcinoma 2025-04-15
A dosimetry study of lutetium (177Lu) rhPSMA-10.1 and lutetium (177Lu) vipivotide tetraxetan (Pluvicto®) in patients with non-curative metas… Ended

2024-515264-31-00 PSMA-positive non-curative metastatic castration-resist 2025-04-15